Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q2 2025 Earnings Call Transcript July 29, 2025
Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $0.23, expectations were $0.18.
Operator: Thank you for standing by, and welcome to the Kiniksa Pharmaceutical Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today’s program is being recorded. And now I’d like to introduce your host for today’s program, Jonathan Kirshenbaum, Investor...
